Cited by 9Amino Acid Enzymes and MetabolismNeuroscience and Neuropharmacology ResearchGlycogen Storage Diseases and Myoclonus

Dual Role of Dysfunctional Asc-1 Transporter in Distinct Human Pathologies, Human Startle Disease, and Developmental Delay

Open access
Drehmann, Paul, Milanos, Sinem, Schaefer, Natascha, Kasaragod, Vikram Babu, Herterich, Sarah, Holzbach-Eberle, Ulrike, Harvey, Robert J., Villmann, Carmen·2023·eneuro

Abstract

Human startle disease is associated with mutations in distinct genes encoding glycine receptors, transporters or interacting proteins at glycinergic synapses in spinal cord and brainstem. However, a significant number of diagnosed patients does not carry a mutation in the common genes GLRA1,GLRB, and SLC6A5. Recently, studies on solute carrier 7 subfamily 10 (SLC7A10; Asc-1, alanine-serine-cysteine transporter) knock-out (KO) mice displaying a startle disease-like phenotype hypothesized that this transporter might represent a novel candidate for human startle disease. Here, we screened 51 patients from our patient cohort negative for the common genes and found three exonic (one missense, two synonymous), seven intronic, and single nucleotide changes in the 5′ and 3′ untranslated regions (UTRs) in Asc-1. The identified missense mutation Asc-1 G307R from a patient with startle disease and developmental delay was investigated in functional studies. At the molecular level, the mutation Asc-1 G307R did not interfere with cell-surface expression, but disrupted glycine uptake. Substitution of glycine at position 307 to other amino acids, e.g., to alanine or tryptophan did not affect trafficking or glycine transport. By contrast, G307K disrupted glycine transport similar to the G307R mutation found in the patient. Structurally, the disrupted function in variants carrying positively charged residues can be explained by local structural rearrangements because of the large positively charged side chain. Thus, our data suggest that SLC7A10 may represent a rare but novel gene associated with human startle disease and developmental delay.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/eneuro.0263-23.2023

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Drehmann, P., Milanos, S., Schaefer, N., Kasaragod, V. B., Herterich, S., Holzbach-Eberle, U., Harvey, R. J., & Villmann, C.
Affiliations
  • University of Würzburg (DE)
  • MRC Laboratory of Molecular Biology (GB)
  • University of the Sunshine Coast (AU)
Corresponding author
Villmann, Carmen
Venue
eneuro
Published
2023-10-30
Volume
10
Issue
11
Pages
ENEURO.0263-23.2023
ISSN
2373-2822 (ISSN-L)
OpenAlex
W4388035555
Cited by
9
References
39
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 1
FWCI
0.91
Type
journal article
Language
en
Open access
Locations
  • eNeuro (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft (VI586)
  • Scientia
  • Willy Robert Pitzer Stiftung
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
Keywords
glycine uptake, developmental delay, missense mutations, glycinergic synapses, spinal cord, brainstem, protein structural rearrangement
MeSH terms
Alanine, Animals, Glycine, Humans, Mutation, Receptors, Glycine, Mutation, Missense, Glycine Plasma Membrane Transport Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review